Personalis Return on Investment 2018-2024 | PSNL

Current and historical return on investment (ROI) values for Personalis (PSNL) over the last 10 years.
Personalis ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $-0.07B inf%
2024-06-30 $-0.09B inf%
2024-03-31 $-0.10B inf%
2023-12-31 $-0.11B inf%
2023-09-30 $-0.12B inf%
2023-06-30 $-0.11B inf%
2023-03-31 $-0.12B inf%
2022-12-31 $-0.12B inf%
2022-09-30 $-0.10B inf%
2022-06-30 $-0.09B inf%
2022-03-31 $-0.08B inf%
2021-12-31 $-0.07B inf%
2021-09-30 $-0.06B inf%
2021-06-30 $-0.05B inf%
2021-03-31 $-0.04B inf%
2020-12-31 $-0.04B inf%
2020-09-30 $-0.04B inf%
2020-06-30 $-0.03B inf%
2020-03-31 $-0.03B -80.00%
2019-12-31 $-0.02B -65.19%
2019-06-30 $-0.01B $0.14B -32.59%
2019-03-31 $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.261B $0.073B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00